ICON Web & News
Virtual Journal
Everything
Resources
Virtual Journal
Analyze Database
GoodNanoGuide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Ratings Comment
Guidelines
Links
Quick Search:
Keywords:
Search:
Search Using OECD Database
Details
Return to Previous Page
Addition or Correction
Title:
In Vitro Evaluation of Theranostic Polymeric Micelles for Imaging and Drug Delivery in Cancer
Date:
7/2012
Link to Journal Abstract
Abstract:
For the past decade engineered nanoplatforms have seen a momentous progress in developing a multimodal theranostic formulation which can be simultaneously used for imaging and therapy. In this report we describe the synthesis and application of theranostic phospholipid based polymeric micelles for optical fluorescence imaging and controlled drug delivery. CdSe quantum dots (QDs) and anti-cancer drug, doxorubicin (Dox), were co-encapsulated into the hydrophobic core of the micelles. The micelles are characterized using optical spectroscopy for characteristic absorbance and fluorescence features of QDs and Dox. TEM and DLS studies yielded a size of <50 nm for the micellar formulations with very narrow size distribution. A sustained release of the drug was observed from the co-encapsulated micellar formulation. In vitro optical fluorescence imaging and cytotoxicity studies with HeLa cell line demonstrated the potential of these micellar systems as efficient optical imaging and therapeutic probes.
Non-technical Summary:
this report we describe the synthesis and application of theranostic phospholipid based polymeric micelles for optical fluorescence imaging and controlled drug delivery. CdSe quantum dots (QDs) and anti-cancer drug, doxorubicin (Dox), were co-encapsulated into the hydrophobic core of the micelles and in vitro optical fluorescence imaging and cytotoxicity studies with HeLa cell line.
Content Emphasis
Peer Reviewed Journal Article
Exposure Or Hazard Target
Mammalian
Exposure Pathway
Other/Unspecified
Method Of Study
In Vitro
Paper Type
Hazard
Particle Type
Semiconductor
Production Method
Engineered
Risk Exposure Group
General Population
Target Audience
Technical Research
Citation:
Theranostics, 2012, 2(7): 714-722
Publication:
Theranostics
Author:
Kumar R, Kulkarni A, Nagesha DK, Sridhar S
Volume:
2
Number:
7
Pages:
714-722
Last updated on October 22, 2012
Permalink
Join Us
|
About
|
Newsroom
|
Working Groups
|
Projects
|
Resources
|
Virtual Journal
|
Events
|
Logout
This work is supported in part by the Nanoscale Science and Engineering Initiative of the National Science Foundation
under NSF Award Number EEC-0118007.
Why Join Us?
Mission and Strategy
Background
Organization
Sponsors
Participants
Contact Us
ICON Releases
News
Media Alert
RSS
Governance
Knowledge Base
Best Practices
Communications
Virtual Journal
Analyze Database
Good Nano Guide
ICON Reports
ICON Backgrounders
Glossary
Policy Reports
Links
Council Events
Other Events
Virtual Journal
Analyze Database
The GoodNanoGuide
Nano EHS Research Needs
Current Practices Survey